109
Views
23
CrossRef citations to date
0
Altmetric
Concise Reviews in Surgery

Strategies for the Prevention and Treatment of Peritoneal Carcinomatosis from Gastrointestinal Cancer

, F.R.C.S. , M.D. , F.A.C.S.
Pages 155-172 | Published online: 11 Jun 2009

References

  • Sugarbaker, P H. Peritonectomy procedures. Ann. Surg. 1995, 221, 29–42. [PUBMED], [INFOTRIEVE]
  • Sugarbaker, P H.; Graves, T.; DeBruijn, E A.; Cunliffe, W J.; Mullins, R E.; Schlag, P. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res. 1990, 50, 5790–5794. [PUBMED], [INFOTRIEVE]
  • Jacquet, P.; Averbach, A.; Stephens, A D.; Stuart, O A.; Chang, D.; Sugarbaker, P H. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 1998, 55 (2), 130–138. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Chu, D Z.J.; Lang, N P.; Thompson, C.; Osteen, P K.; Westbrook, K C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989, 63, 364–367. [PUBMED], [INFOTRIEVE]
  • Sadeghi, B.; Arvieux, C.; Glehen, O.; Beaujard, A C.; Rivoire, M.; Baulieux, J.; Fontaumard, E.; Brachet, A.; Caillot, J L.; Faure, J L.; Porcheron, J.; Peix, J L.; Francois, Y.; Vignal, J.; Gilly, F N. Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88, 358–363. [PUBMED], [INFOTRIEVE]
  • Jayne, D G.; Fook, S.; Loi, C.; Seow-Choen, F. Peritoneal carcinomatosis from colorectal cancer. Br. J. Surg. 2002, 89, 1454–1550.
  • Sampson, J A. Implantation peritoneal carcinomatosis of ovarian origin. Am. J. Pathol. 1931, VII, 423–443.
  • Weiss, L. Metastatic inefficiency: causes and consequences. Cancer Rev. 1986, 3, 1–24.
  • Kodera, Y.; Yamamura, Y.; Shimizu, Y.; Torii, A.; Hirai, T.; Yasui, K.; Morimoto, T.; Kato, T. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J. Surg. Oncol. 1999, 72, 60–65. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zoetmulder, F A.N. Modelstudies Over Het Colorectale Carcinoom; Rodopi: Amsterdam, 1982.
  • Autio, V. The spread of intraperitoneal infection. Studies with Roentgen contrast medium. Acta Chirurg. Scand. 1964, Supplementum 321, 5–31.
  • Meyers, M A. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1973, 119, 198–206. [PUBMED], [INFOTRIEVE]
  • Hagiwara, A.; Sawai, K.; Sakakura, C.; Shirasu, M.; Ohgaki, M.; Yamasaki, J.; Togawa, T.; Takahashi, T. Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum. Hepato-Gastroenterol. 1998, 45, 1922–1929. [CSA]
  • Sugarbaker, P H. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In Peritoneal Carcinomatosis: Principles of Management; Sugarbaker, P H., Ed.; Kluwer: Boston, 1996; 79–100.
  • Carmignani, C P.; Sugarbaker, T.; Bromley, C M.; Sugarbaker, P H. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread if already been published. Metastases Rev. 2003, 22, 465–472. [CROSSREF], [CSA]
  • Ronnett, B M.; Yan, H.; Kurman, R J.; Shmookler, B M.; Wu, L.; Sugarbaker, P H. Pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis has a significantly more favorable prognosis than peritoneal mucinous carcinomatosis. Cancer 2001, 92 (1), 85–91. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Archer, A G.; Sugarbaker, P H.; Jelinek, J S. Radiology of peritoneal carcinomatosis. In Peritoneal Carcinomatosis: Principles of Management; Sugarbaker, P H., Ed.; Kluwer: Boston, 1996; 263–288.
  • Jacquet, P.; Jelinek, J S.; Chang, D.; Koslowe, P.; Sugarbaker, P H. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J. Am. Coll. Surg. 1995, 181, 530–538. [PUBMED], [INFOTRIEVE], [CSA]
  • Ottow, R T.; Steller, E P.; Sugarbaker, P H.; Wesley, R A.; Rosenberg, S A. Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models. Cell. Immunol. 1987, 104, 366–376. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Gomez Portilla, A.; Sugarbaker, P H.; Chang, D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic factors. World J. Surg. 1999, 23, 23–29. [CROSSREF]
  • Berthet, B.; Sugarbaker, T A.; Chang, D.; Sugarbaker, P H. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur. J. Cancer 1999, 35, 413–419. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sugarbaker, P H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother. Pharmacol. 1999, 43 (Suppl.), S15–S25. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sugarbaker, P H. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann. Surg. Oncol. 1999, 6 (8), 727–731. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Elias, D.; Blot, F.; El Otmany, A.; Antoun, S.; Lasser, P.; Boige, V.; Rougier, P.; Ducreux, M. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001, 92, 71–76. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Witkamp, A J.; de Bree, E.; Kaag, M M.; van Slooten, G W.; van Coeverden, F.; Zoetmulder, F A.N. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br. J. Surg. 2001, 88, 458–463. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Shen, P.; Levine, E A.; Hall, J.; Case, D.; Russell, G.; Fleming, R.; McQuellon, R.; Geisinger, K R.; Loggie, B W. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch. Surg. 2003, 138, 26–33. [PUBMED], [INFOTRIEVE], [CSA]
  • Verwaal, V J.; van Ruth, S.; de Bree, E.; van Sloothe, G W.; van Tinteren, H.; Boot, H.; Zoetmulder, F A. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versussystemic chemotherapy and palliative surgery in patients with peritoneal carinomatosis of colorectal cancer. J. Clin. Oncol. 2003, 21 (20), 3737–3743. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sugarbaker, P H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother. Pharmacol. 1999, 43 (Suppl.), S15–S25. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sugarbaker, P H.; Yonemura, Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 2000, 58, 96–107. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Sugarbaker, P H. Perioperative intraperitoneal chemotherapy in resectable gastric cancer: surgical responsibilities. In Seminars in Surgical Oncology; Rich, T A., Ed.; 2003; Vol. 21, 233–248.
  • Yu, W.; Whang, I.; Young, C.; Averbach, A.; Sugarbaker, P H. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J. Surg. 2001, 25 (8), 985–990. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sugarbaker, P H.; Acherman, Y I.Z.; Gonzalez-Moreno, S.; Ortega-Perez, G.; Stuart, O A.; Marchettini, P.; Yoo, D. Diagnosis and treatment of peritoneal mesothelioma: the Washington Cancer Institute experience. Semin. Oncol. 2002, 29 (1), 51–61. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sugarbaker, P H.; Jablonski, K A. Prognostic factors of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Surg. 1995, 221 (2), 124–132. [PUBMED], [INFOTRIEVE]
  • Stephens, A D.; Alderman, R.; Chang, D.; Edwards, G D.; Esquivel, J.; Sebbag, G.; Steves, M A.; Sugarbaker, P H. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann. Surg. Oncol. 1999, 6 (8), 790–796. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Gonzalez-Bayon, L.; Sugarbaker, P H.; Gonzalez-Moreno, S.; Vazquez, V L.; Alves, S.; Moran, B. Initiation of a program in peritoneal surface malignancy. In Management of Peritoneal Surface Malignancy. Surg. Oncol. Clin. N. Am.; Sugarbaker, P H., Ed.; 2003; Vol. 12, 741–753.
  • McQuellon, R P.; Loggie, B W.; Fleming, R A.; Russell, G B.; Lehman, A B.; Rambo, T D. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur. J. Surg. Oncol. 2001, 27, 65–73. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Sugarbaker, P H. (Editorial) Carcinomatosis, is cure an option? J. Clin. Oncol. 2003, 21, 762–764. [PUBMED], [INFOTRIEVE], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.